96 related articles for article (PubMed ID: 28006662)
1. Potent anticancer activity of a new bismuth (III) complex against human lung cancer cells.
Ouyang R; Yang Y; Tong X; Feng K; Yang Y; Tao H; Zhang X; Zong T; Cao P; Xiong F; Guo N; Li Y; Miao Y; Zhou S
J Inorg Biochem; 2017 Mar; 168():18-26. PubMed ID: 28006662
[TBL] [Abstract][Full Text] [Related]
2. A nine-coordinated bismuth(III) complex derived from pentadentate 2,6-diacetylpyridine bis((4)N-methylthiosemicarbazone): crystal structure and both in vitro and in vivo biological evaluation.
Li MX; Yang M; Niu JY; Zhang LZ; Xie SQ
Inorg Chem; 2012 Nov; 51(22):12521-6. PubMed ID: 23136979
[TBL] [Abstract][Full Text] [Related]
3. Syntheses, crystal structures and antimicrobial activities of monomeric 8-coordinate, and dimeric and monomeric 7-coordinate bismuth(III) complexes with tridentate and pentadentate thiosemicarbazones and pentadentate semicarbazone ligands.
Nomiya K; Sekino K; Ishikawa M; Honda A; Yokoyama M; Chikaraishi Kasuga N; Yokoyama H; Nakano S; Onodera K
J Inorg Biochem; 2004 Apr; 98(4):601-15. PubMed ID: 15041240
[TBL] [Abstract][Full Text] [Related]
4. One dodecahedral bismuth(III) complex derived from 2-acetylpyridine N(4)-pyridylthiosemicarbazone: synthesis, crystal structure and biological evaluation.
Li M; Lu Y; Yang M; Li Y; Zhang L; Xie S
Dalton Trans; 2012 Nov; 41(41):12882-7. PubMed ID: 22986888
[TBL] [Abstract][Full Text] [Related]
5. Coordination environment dependence of anticancer activity in cyclometalated bismuth(III) complexes with C,O-chelating ligands.
Lei J; Liu Y; Yin M; Li S; Wang Z; Chen Y
J Inorg Biochem; 2024 Jul; 256():112571. PubMed ID: 38669912
[TBL] [Abstract][Full Text] [Related]
6. Improvement in the Anticancer Activity of 6-Mercaptopurine via Combination with Bismuth(III).
Yang Y; Zhou S; Ouyang R; Yang Y; Tao H; Feng K; Zhang X; Xiong F; Guo N; Zong T; Cao P; Li Y; Miao Y
Chem Pharm Bull (Tokyo); 2016; 64(11):1539-1545. PubMed ID: 27803465
[TBL] [Abstract][Full Text] [Related]
7. Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft.
Kong M; Fan J; Dong A; Cheng H; Xu R
Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):827-33. PubMed ID: 20978038
[TBL] [Abstract][Full Text] [Related]
8. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
[TBL] [Abstract][Full Text] [Related]
9. TXA9, a cardiac glycoside from Streptocaulon juventas, exerts a potent anti-tumor activity against human non-small cell lung cancer cells in vitro and in vivo.
Xue R; Han N; Xia M; Ye C; Hao Z; Wang L; Wang Y; Yang J; Saiki I; Yin J
Steroids; 2015 Feb; 94():51-9. PubMed ID: 25555472
[TBL] [Abstract][Full Text] [Related]
10. Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
J Inorg Biochem; 2013 Nov; 128():68-76. PubMed ID: 23948576
[TBL] [Abstract][Full Text] [Related]
11. Bismuth(III) complexes with 2-acetylpyridine- and 2-benzoylpyridine-derived hydrazones: Antimicrobial and cytotoxic activities and effects on the clonogenic survival of human solid tumor cells.
Ferreira IP; Piló EDL; Recio-Despaigne AA; Da Silva JG; Ramos JP; Marques LB; Prazeres PHDM; Takahashi JA; Souza-Fagundes EM; Rocha W; Beraldo H
Bioorg Med Chem; 2016 Jul; 24(13):2988-2998. PubMed ID: 27209169
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protein kinase C α/βII and activation of c-Jun NH2-terminal kinase mediate glycyrrhetinic acid induced apoptosis in non-small cell lung cancer NCI-H460 cells.
Song J; Ko HS; Sohn EJ; Kim B; Kim JH; Kim HJ; Kim C; Kim JE; Kim SH
Bioorg Med Chem Lett; 2014 Feb; 24(4):1188-91. PubMed ID: 24461294
[TBL] [Abstract][Full Text] [Related]
13. Studies on the cytotoxicity and anticancer performance of heterocyclic hypervalent organobismuth(III) compounds.
Liu YP; Lei J; Tang LW; Peng Y; Au CT; Chen Y; Yin SF
Eur J Med Chem; 2017 Oct; 139():826-835. PubMed ID: 28865278
[TBL] [Abstract][Full Text] [Related]
14. Recent Research Trends on Bismuth Compounds in Cancer Chemoand Radiotherapy.
Kowalik M; Masternak J; Barszcz B
Curr Med Chem; 2019; 26(4):729-759. PubMed ID: 28971764
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.
Guichard SM; Else R; Reid E; Zeitlin B; Aird R; Muir M; Dodds M; Fiebig H; Sadler PJ; Jodrell DI
Biochem Pharmacol; 2006 Feb; 71(4):408-15. PubMed ID: 16360645
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
Islam A; Rodrigues BL; Marzano IM; Perreira-Maia EC; Dittz D; Paz Lopes MT; Ishfaq M; Frézard F; Demicheli C
Eur J Med Chem; 2016 Feb; 109():254-67. PubMed ID: 26774931
[TBL] [Abstract][Full Text] [Related]
17. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
18. Developing a binuclear multi-target Bi(III) complex by optimizing 2-acetyl-3-ethylpyrazine thiosemicarbazides.
Khan MH; Cai M; Li S; Zhang Z; Zhang J; Wen X; Sun H; Liang H; Yang F
Eur J Med Chem; 2019 Nov; 182():111616. PubMed ID: 31425907
[TBL] [Abstract][Full Text] [Related]
19. 8-Cetylberberine inhibits growth of lung cancer in vitro and in vivo.
Xiao Y; Tian C; Huang T; Han B; Wang M; Ma H; Li Z; Ye X; Li X
Life Sci; 2018 Jan; 192():259-269. PubMed ID: 29138118
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
